One year ago millions of obese Americans were waiting to hear whether or not the Food and Drugs Agency would give approval to the diet drug rimonabant, banded as Acomplia in Europe. Obviously there was huge disappointment when this approval …

Conquering the unhealthy craving for food is not an easy task. Unhealthy craving for food often results in obesity. Obesity is a chronic dietary disorder which can push you in the clutches of various health related risk factors like diabetes, …

Sanofi-Aventis, a drug company based in France, developed and tested Acomplia (Rimonabant). The new drug appears to be exceptionally effective in treating not only obesity but in helping to reduce weight-related risk factors for heart disease and other conditions. Acomplia …